...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: What Monday Brings?
5
Jun 16, 2016 06:41PM
6
Jun 16, 2016 11:26PM
1
Jun 17, 2016 08:04AM
4
Jun 17, 2016 09:18AM
6
Jun 17, 2016 09:36AM
1
Jun 17, 2016 09:50AM

Not a case of being uniformed or ignoring past Zenith communications. I also was not intentionally negative. And you are 100% correct that there are many positive things that are happening with Zenith right now, and I am looking forward for the updates on these.

I was just musing that IMHO I don't forsee (upon the split of ZEL and ZCC) a quick listing of ZEL. So although the potential in the longer term is very positive, those hoping to get some liquidity from ZEL in the short term should not hold their breath. That is all.

5
Jun 17, 2016 11:45AM
4
Jun 17, 2016 07:12PM
Share
New Message
Please login to post a reply